Shots:
Boston Scientific entered into a definitive agreement to acquire SoniVie Ltd. to expand itsĀ interventional cardiology therapies offerings
Currently, the company holds an equity stake of approx. 10%, and for the remaining 90% stake, the company will pay approx. $360M upfront and up to $180M regulatory milestones; for 100% stake, the amount sums…
